These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35779664)

  • 1. Targeting Effect of Betulinic Acid Liposome Modified by Hyaluronic Acid on Hepatoma Cells In Vitro.
    Wu X; Wei Z; Feng H; Chen H; Xie J; Huang Y; Wang M; Yao C; Huang J
    J Pharm Sci; 2022 Nov; 111(11):3047-3053. PubMed ID: 35779664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Characterization of Liposomes Modified with Biosurfactant MEL-A Loading Betulinic Acid and Its Anticancer Effect in HepG2 Cell.
    Shu Q; Wu J; Chen Q
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eudragit S100 prepared pH-responsive liposomes-loaded betulinic acid against colorectal cancer
    Wang G; Yang Y; Yi D; Yuan L; Yin PH; Ke X; Jun-Jie W; Tao MF
    J Liposome Res; 2022 Sep; 32(3):250-264. PubMed ID: 34895013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-p66(shc)/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma.
    Yang J; Qiu B; Li X; Zhang H; Liu W
    Toxicol Lett; 2015 Nov; 238(3):1-10. PubMed ID: 26222667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic synthesis and in vitro evaluation of folate-functionalized liposomes.
    Guo B; Xu D; Liu X; Yi J
    Drug Des Devel Ther; 2017; 11():1839-1847. PubMed ID: 28684902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research on the synthesis of nanoparticles of betulinic acid and their targeting antitumor activity.
    Chen X; Lu S; Gong F; Sui X; Liu T; Wang T
    J Biomed Mater Res B Appl Biomater; 2022 Aug; 110(8):1789-1795. PubMed ID: 35179806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes.
    Liu Y; Gao D; Zhang X; Liu Z; Dai K; Ji B; Wang Q; Luo L
    Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():124-132. PubMed ID: 27127036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems.
    Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K
    Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
    Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
    Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
    Tao R; Wang C; Lu Y; Zhang C; Zhou H; Chen H; Li W
    Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic acid induces autophagy-dependent apoptosis via Bmi-1/ROS/AMPK-mTOR-ULK1 axis in human bladder cancer cells.
    Zhang Y; He N; Zhou X; Wang F; Cai H; Huang SH; Chen X; Hu Z; Jin X
    Aging (Albany NY); 2021 Sep; 13(17):21251-21267. PubMed ID: 34510030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progress.
    Chen Y; Wu X; Liu C; Zhou Y
    Cell Biochem Funct; 2020 Aug; 38(6):702-709. PubMed ID: 32283563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved anticancer activity of betulinic acid on breast cancer through a grafted copolymer-based micelles system.
    Qi X; Gao C; Yin C; Fan J; Wu X; Guo C
    Drug Deliv; 2021 Dec; 28(1):1962-1971. PubMed ID: 34565273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
    Feng S; Wu ZX; Zhao Z; Liu J; Sun K; Guo C; Wang H; Wu Z
    ACS Appl Mater Interfaces; 2019 Feb; 11(7):7357-7368. PubMed ID: 30682240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hyaluronic acid-modified imatinib mesylate cubosomes through CD44 targeted drug delivery in NDEA-induced hepatic carcinoma.
    Nisha R; Kumar P; Kumar U; Mishra N; Maurya P; Singh P; Tabassum H; Alka ; Singh S; Guleria A; Saraf SA
    Int J Pharm; 2022 Jun; 622():121848. PubMed ID: 35613653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betulinic Acid Restricts Human Bladder Cancer Cell Proliferation In Vitro by Inducing Caspase-Dependent Cell Death and Cell Cycle Arrest, and Decreasing Metastatic Potential.
    Kim SY; Hwangbo H; Kim MY; Ji SY; Kim DH; Lee H; Kim GY; Moon SK; Leem SH; Yun SJ; Kim WJ; Cheong J; Park C; Choi YH
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes.
    Qhattal HS; Liu X
    Mol Pharm; 2011 Aug; 8(4):1233-46. PubMed ID: 21696190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.